Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mary Dibiase currently holds 289,110 shares of X4 Pharmaceuticals, Inc (XFOR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mary Dibiase has been a net seller of XFOR stock. They have purchased $0 and sold $95.5K worth of shares.
Mary Dibiase's most recent insider trade was on Sep 9, 2024, when they sold 2,642 shares at $0.66 per share.
Mary Dibiase serves as Executive at X4 Pharmaceuticals, Inc (XFOR). They have executed 19 insider transactions totaling $95.5K over their tenure at the company.
Mary Dibiase holds the position of Executive at X4 Pharmaceuticals, Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Mary Dibiase has shown a selling trading pattern, with $0 in total purchases and $95.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mary Dibiase was on Nov 1, 2023, when they sold $49.4K worth of XFOR shares. This transaction involved 67,695 shares at $0.73 per share.
Mary Dibiase currently owns 289,110 shares of X4 Pharmaceuticals, Inc (XFOR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mary Dibiase's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mary Dibiase has 19 Form 4 filings on record as an insider at X4 Pharmaceuticals, Inc.
Set alerts for Mary Dibiase and 40,000+ other insiders.